• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchHanx Biopharmaceuticals (Wuhan)
    Picture of Hanx Biopharmaceuticals (Wuhan) logo

    3378 — Hanx Biopharmaceuticals (Wuhan) Share News

    HK$26.780.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    • Market Cap
      HK$3.59bn
    • Enterprise Value
      HK$3.10bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 3378 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    3378 Dividends
    • Brief: Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research

      21/09/2026 11:40
    • Brief: Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab

      07/07/2026 15:18
    • Brief: Hanx Biopharmaceuticals (Wuhan) And Twinedge Bioscience Initiates Research Collaboration

      02/07/2026 18:11
    • Farmers in biggest cocoa producer are very short of fertilizer, survey says

      28/04/2026 19:06
    • Brief: Hanx Biopharmaceuticals (Wuhan) Says Xiao Jieyu Re-Designated As Executive Director

      04/02/2026 16:59
    • Brief: Hanx Biopharmaceuticals (Wuhan) Says HX111 Received Approval For Clinical Trials In China

      23/12/2025 15:37
    • Brief: Hanx Biopharmaceuticals (Wuhan) Sets Final Offer Price HK$32.00 Per H Share

      22/12/2025 15:24

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.